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Abstract
Pregnancy associated plasma protein A2 (PAPP-A2) is a protease of insulin-like growth factor binding protein 5 and is
receiving increasing attention for its roles in pregnancy and postnatal growth. The goals of the present study were to
characterize the effects of PAPP-A2 deletion on bone size and shape in mice at 10 weeks of age, and to determine whether
Pappa2 is the gene responsible for a previously-identified quantitative trait locus (QTL) contributing to natural variation in
postnatal growth in mice. Mice homozygous for constitutive PAPP-A2 deletion were lighter than wild-type littermates, and
had smaller mandible dimensions and shorter skull, humerus, femur, tibia, pelvic girdle, and tail bone. Furthermore, PAPP-
A2 deletion reduced mandible dimensions and the lengths of the skull, femur, pelvic girdle, and tail bone more than would
be expected due to the effect on body mass. In addition to its effects on bone size, PAPP-A2 deficiency also altered the
shape of the mandible and pelvic girdle, as assessed by geometric morphometrics. Mice homozygous for the PAPP-A2
deletion had less deep mandibles, and pelvic girdles with a more feminine shape. Using a quantitative complementation
test, we confirmed that Pappa2 is responsible for the effects of the previously-identified QTL, demonstrating that natural
variation in the Pappa2 gene contributes to variation in postnatal growth in mice. If similar functional variation in the
Pappa2 gene exists in other species, effects of this variation on the shape of the pelvic girdle might explain the previously-
reported associations between Pappa2 SNPs and developmental dysplasia of the hip in humans, and birthing in cattle.
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Introduction
Insulin-like growth factors (IGFs) play a pivotal role in growth
and development [1]. The bioavailability of the IGFs is regulated
by six IGF binding proteins (IGFBPs), and the release of IGFs and
subsequent IGF signaling is achieved through cleavage of the
IGFBPs by proteases [1]. Pregnancy associated plasma protein A
(PAPP-A) is an IGFBP protease that was initially identified as
a circulating protein of placental origin, but has since been shown
to play roles outside of pregnancy in cardiovascular disease, the
regulation of bone mineral density, skin healing and aging
[2,3,4,5,6]. Screening of sequence databases for homologs of
PAPP-A subsequently identified PAPP-A2, an IGFBP-5 protease
that shares 45% amino acid sequence identity with PAPP-A [7].
While less work has examined PAPP-A2, this protein is receiving
increasing attention for its roles in human pregnancy [2,8],
reproductive traits in cattle [9,10,11], and postnatal growth in
mice [12,13].
The first indication of a role in postnatal growth was our
previous work that identified Pappa2 as a candidate for the gene
responsible for the effects of a quantitative trait locus (QTL)
affecting adult body size in mice. We refined the location of the
QTL to a 1 megabase (MB) region that contains only 4 genes, and
found that the QTL affected circulating levels of IGFBP-5, the
target of PAPP-A2 [12]. Recently, Conover et al. developed
PAPP-A2 knock-out mice which are viable and smaller than wild-
type [13]. Because IGFBP-5 is known to play a role in bone
metabolism [14,15], PAPP-A2 is expected to have a particularly
pronounced effect on skeletal growth. Deletion of PAPP-A2 leads
to shorter femur length, but no effects on bone mineral density
were detected [13]. The QTL described above also affects the
length of certain bones [16]. In cattle, associations have been
found between SNPs in Pappa2 and difficulty giving birth,
potentially through effects on the size or shape of the mother’s
pelvis [10]. Others have reported association between develop-
mental dysplasia of the hip and a Pappa2 SNP in humans [17],
again suggesting an effect of PAPP-A2 on bone shape.
The goals of the present study were to further characterize the
effects of PAPP-A2 deletion on skeletal characters in mice,
including not only bone lengths but also bone shapes, and to
determine whether Pappa2 is the gene responsible for the QTL
described above [12]. Although Pappa2 was previously identified as
a candidate for a QTL affecting body size [12], and deletion of
PAPP-A2 reduces body size [13], it does not necessarily follow that
Pappa2 is responsible for the effects of the QTL; there might be no
functional variation in the Pappa2 gene between the two wild-type
mouse strains studied in the QTL work. To test whether Pappa2 is
the causal gene underlying the QTL, we performed a quantitative
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complementation test [18,19,20]. Establishing whether Pappa2 is
responsible for the effects of the QTL will shed light on the
functional significance of naturally-occurring variation in this
gene, and will help to identify functionally important coding and
regulatory regions.
Methods
Ethics Statement
All work was carried out in accordance with the guidelines of
the Canadian Council on Animal Care and approved by the SFU
University Animal Care Committee (protocol 945B-09).
PAPP-A2 Deletion Mice
Conditional PAPP-A2 deletion mice were generated by Ozgene
Pty. Ltd. (Bentley, Australia), i.e., independently of the previous
PAPP-A2 deletion study [13]. The targeting vector was con-
structed using Ozgene’s Pelle plasmid and fragments generated by
PCR from C57BL/6 genomic DNA, such that mouse exon 2
(homologous to human exon 3) and a PGK-Neo selection cassette
were flanked by LoxP sites (i.e., ‘‘floxed’’, Fig. 1). Following Cre-
mediated deletion of exon 2, splicing of exon 1 to exon 3 is
expected to produce an early stop codon. The targeting vector was
electroporated into C57BL/6 ES cells and correctly targeted
clones were injected into blastocysts for the generation of
chimeras. High percentage chimeras were mated with C57BL/6
mice to produce offspring heterozygous for the floxed allele.
Deletion of exon 2 and removal of the Neo cassette were
achieved by crossing conditional deletion mice to mice with
a C57BL/6 background expressing Cre recombinase (hereafter
referred to as Cre) under the control of a human cytomegalovirus
minimal promoter (Jackson Laboratory stock number 006054).
Removal of the floxed region in the progeny was determined by
PCR genotyping (described below). In subsequent experiments
(described below), we tested whether Cre itself had an effect on
phenotype in preliminary analyses in which we included the
presence of Cre (yes/no) as a term in the model. The presence of
Cre did not have a significant (P,0.05) effect on body mass or tail
length at any age, or on any bone phenotype, in analyses of the
effects of PAPP-A2 deletion or the quantitative complementation
test, with one exception: the effect of Cre was significant for tail
length at 3 weeks of age in the quantitative complementation test,
but not in the analyses of the effects of PAPP-A2 deletion. Since
the presence of Cre affected only one trait in only one of two
experiments, this variable was removed from the model for further
analyses.
Mice heterozygous for the constitutive Pappa2 disruption were
paired to produce litters in which all three genotypes were present
(i.e., homozygous disruption, heterozygous, and homozygous wild-
type). For measuring placental and embryonic weights and PAPP-
A2 expression, females were checked for seminal plugs the
morning following pairing, and plugged females were euthanized
with CO2 twelve days later (embryonic day 12.5). We chose to
collect females at embryonic day 12.5 to ensure that individual
placentae and embryos would be sufficiently large for protein
extraction and because PAPP-A2 expression is high at this stage
[21,22]. Placentae and embryos were dissected while immersed in
106 PBS, weighed, and frozen at 280uC for quantification of
protein levels by Western blotting. The amniotic sac and/or
a piece of embryonic tail was collected for PCR genotyping.
To determine birth weight, females were not checked for plugs,
but were instead left with males, checked daily three to five hours
after the lights were turned on, and new pups were weighed. We
anaesthetized the newborn offspring using isofluorane, and
collected 2 mm of tail tissue for genotyping. These pups were
also earclipped for genotyping at 3 weeks of age and weighed at 3,
6 and 10 weeks of age. Additional mice were not weighed at birth,
but earclipped for genotyping at 3 weeks of age, and mass and tail
length were measured at 3, 6 and 10 weeks of age.
Bone Measurements
Following sacrifice at 10 weeks of age, mice were frozen and
thawed at a later date at which time the skin and internal organs
were removed and the carcasses were dried and then exposed to
dermestid beetles to remove soft tissue. The following bones were
measured: mandible length (distance from the tip of the angular
process to the anterior edge of the molars, mandible height (from
the coronoid process to the tip of the angular process), and the
lengths of the skull, humerus, ulna/radius, femur, tibia, pelvic
girdle, and a tail bone (the tenth caudal bone counting from the
first bone of the sacrum). Where applicable we measured bones
from both sides of each animal and calculated the mean. All
Figure 1. Schematic diagram of the targeting vector used in the generation of PAPP-A2 conditional deletion mice. Shown are the
locations of the targeted exon, homology arms, loxP and FRT sites, ampicillin resistance gene (AmpR), phosphoglycerate kinase promoter (PGK),
neomycin resistance gene (Neo), bovine growth hormone poly A termination signal (pA), and genotyping primers. The sizes of the primers have been
exaggerated for clarity.
doi:10.1371/journal.pone.0056260.g001
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skeletal dimensions were measured with digital calipers
(60.01 mm) and measurements were performed in triplicate.
Shape Analysis
In addition to linear size measurements, the shapes of the
mandible and pelvic girdle were analyzed. Photographs were taken
of the left and right mandible, and left and right pelvic girdles.
Landmarks were placed on photos using the tpsDig2 program (tps
software package, version 2.16; F. James Rohlf; http://life.bio.
sunysb.edu/morph/), with 12 landmarks for mandibles and 14 for
the pelvic girdles. The tpsDig2 software was also used to create
outline images representing the curvature of the bones, used to
visualize differences in bone shape. The tpsUtil program (tps utility
software, version 1.49; F. James Rohlf; http://life.bio.sunysb.edu/
morph/) was used to form the tps input files.
Procrustes analysis was performed on landmark data using
MorphoJ (version 1.05a; C.P. Klingenberg; http://www.flywings.
org.uk/MorphoJ_page.htm [23]). The Procrustes analysis uses
superimposition to reorient and scale the imported landmark
coordinates so they are aligned in the same position and at
approximately the same size in order to quantify variation at each
landmark coordinate regardless of size or original positioning in
the photograph [24]. This analysis also accounts for symmetry
between the left and right bones, and left and right bones from
a given mouse were subsequently averaged. The Procrustes
analysis yields centroid size, a measure of size, and Procrustes
coordinates, which provide information on shape, independent of
size. Procrustes coordinates were analysed using Principal
Component Analysis (PCA) to reduce the dimensionality of the
data, i.e., to reduce the multiple distances between coordinates to
a smaller number of variables. PCA was performed using the
pooled within-group covariance (within litter, sex and genotype).
PCA scores, as well as centroid data, were exported from MorphoJ
into SAS, Version 9.3 (SAS Institute Inc., Cary, NC) for further
analyses. To facilitate comparisons between PAPP-A2 deletion
mice and mice from the quantitative complementation test
(described below), mice from both experiments were combined
for the PCA such that principal component scores describe the
same variation in shape for all mice.
Quantitative Complementation Test
A quantitative complementation test is used to test whether
a gene is the causal agent underlying a QTL. The logic is as
follows: An individual heterozygous for a knock-out of gene X is
crossed with an individual heterozygous for two QTL alleles,
producing offspring that vary both for the knock-out and for the
QTL alleles. These offspring are measured for the phenotype of
interest, i.e., the trait known to be affected by the QTL. If gene X
is not the gene responsible for the QTL, and if gene X does not
interact with the gene responsible for the QTL, there will be an
effect of QTL allele on the phenotype, and there may be an effect
of the knock-out on phenotype, but these two effects will be
independent of one another, i.e., there will be no statistical
interaction between the effect of the knock-out and the effect of the
QTL. Conversely, if gene X is the gene responsible, or interacts
with the gene responsible for the effect of the QTL, there will be
an interaction between the effects of the QTL allele and the effect
of the knock-out, i.e., the phenotypic effect of the QTL allele will
depend on whether gene X is knocked out or not (see Table 1).
In previous work, we introgressed the C57BL/6 allele of
a chromosome 1 QTL into the DBA/2 background to produce
a line segregating for an approximately 1 MB region containing
the QTL, including Pappa2 [12]. This line was at backcross
generation 14 at the time of this study. The quantitative
complementation test was carried out by crossing mice heterozy-
gous for the QTL allele with mice heterozygous for constitutive
Pappa2 disruption (described above). The offspring inherited either
the C57BL/6 allele or DBA/2 allele of the introgressed segment
from their QTL line parent, and either the Pappa2 disruption allele
or the wild-type allele from their disruption parent. Outside of the
1 MB QTL region, the offspring all had the same C57BL/6 -
DBA/2 heterozygous genetic background. Offspring were ear-
clipped for genotyping at 3 weeks of age, and mass and tail length
were measured at 3, 6 and 10 weeks of age.
Genotyping
Extraction of genomic DNA from ear clips was performed by
standard methods. PCR genotyping was used for the determina-
tion of (a) Pappa2 alleles (wild-type vs. disrupted), (b) QTL alleles
(DBA/2 vs. C57BL/6) and (c) the presence/absence of the Cre
recombinase gene. Genotyping for the Pappa2 allele used 4 primers
at locations shown in Fig. 1. These primers were designed to yield
bands of different sizes for the four possible alleles (408 bp for
wild-type, 308 bp for deleted, 341 bp for floxed with the Neo
selection cassette present, and 547 bp for floxed with the Neo
selection cassette absent; only the first two alleles were present in
this study). Genotyping of QTL alleles was performed by
amplifying two fragments at either end of the QTL region. These
fragments were then digested by XbaI which cut only one of the
alleles due to a SNP in the restriction site, generating a restriction
fragment length polymorphism. The genotyping reactions for Cre
included two primer pairs recommended by the Jackson Labora-
tory: one to amplify a fragment from the Cre transgene and one to
amplify a positive control fragment to confirm that the PCR was
successful; the positive control primers target an exon of the
interleukin 2 gene on chromosome 3. Primer sequences are
provided in Table 2.
Protein Extraction and Western Blotting
Placentae and embryos were homogenized in 2 mL of T-
PERTM Tissue Protein Extraction Reagent (PIERCE, Rockford,
IL), incubated on ice for 7 minutes and then centrifuged at
10000 g for 5 minutes at 4uC. Complete protease inhibitor
cocktail (Roche Applied Sciences) was added to the supernatant,
which was then stored at 220uC.
Placental and embryonic samples containing 40 mg of protein
were mixed with SDS loading buffer, boiled and run through a 4%
stacking and 8% separating polyacrylamide gel for 60 minutes.
The gel was equilibrated in transfer buffer and transferred onto
a nitrocellulose membrane (Bio-Rad, Hercules, CA). Membranes
were blocked for one hour at room temperature in Odyssey
Blocking Buffer (Li-Cor Biosciences, Lincoln, Nebraska), incubat-
ed for one hour at room temperature (placentae) or overnight at
4uC (embryos) in a solution containing 1:500 monoclonal mouse
anti-actin (CLT9001; Cedarlane, Burlington ON) and 1:500
polyclonal goat-anti-human PAPP-A2 antibody (AF1668; R&D
Systems, Minneapolis, MN) diluted in Odyssey Blocking Buffer
(Li-Cor Biosciences, Lincoln, NE) and 0.1% Tween-20 (Sigma,
ON, Canada), washed 4 times, and incubated in a solution
containing 1:10000 fluorescently-labelled IRDye 800 anti-goat
and IRDye 680 anti-mouse secondary antibodies (Li-Cor
Biosciences, Lincoln, NE) diluted in Odyssey Blocking Buffer,
0.1% Tween-20 and 0.1% SDS for 45 minutes with gentle
shaking. The membranes were again washed 4 times. Membranes
were visualized using the Odyssey infrared imaging system (Li-Cor
Biosciences, Lincoln, NE). The two secondary dyes fluoresce at
different wavelengths (anti-goat at 800 nm and anti-mouse at
700 nm), so we were able to simultaneously quantify the intensity
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of the PAPP-A2 band (at approximately 250 kDa) and actin band
(at approximately 40 kDa) on the same nitrocellulose membrane.
Statistical Analyses
All statistical analyses were performed using general linear
models (proc GLM) in SAS, Version 9.3 (SAS Institute Inc., Cary,
NC).
Results
PAPP-A2 Deletion
Following Cre-mediated excision of the floxed region, bands of
the expected size were obtained from PCR (data not shown) and
PAPP-A2 protein was not detectable in placentae or embryos
homozygous for the disrupted allele, and PAPP-A2 levels in
heterozygotes were lower than those in homozygous wild-types
(Fig. 2). In crosses between mice heterozygous for the disruption,
the offspring genotypes did not differ from the expected
Mendelian ratios in utero, at birth, or at weaning (Table 3),
suggesting no effect of PAPP-A2 deletion on viability.
Effects of PAPP-A2 Deletion on Mass and Size
At embryonic day 12.5, there was no detectable effect of PAPP-
A2 deletion on placental or embryonic mass (Table 4). There was
marginally non-significant variation among genotypes in birth
mass (F2,53 = 2.54; P= 0.09), with a trend towards lower birth mass
in pups homozygous for the PAPP-A2 deletion (Table 4). In
MANOVA of size at 3, 6, and 10 weeks of age, the effect of PAPP-
A2 genotype was significant for both body mass (Wilks’ Lambda
F6,140 = 9.81; P = 0.0001) and tail length (Wilks’ Lambda
F6,38 = 8.75; P= 0.0001), and so further single variable tests were
performed. The effect of PAPP-A2 deletion generally did not
depend on sex; the only significant genotype by sex interaction
(F2,71 = 3.30; P= 0.04) was for mass at 6 weeks. Removing the
genotype by sex interaction term from the model, variation among
genotypes was significant for body mass at 3 weeks and for body
mass and tail length at 6, and 10 weeks of age (Table 4); the effect
on 3 week tail length was marginally non-significant (F2,24 = 2.82;
P= 0.08). For all traits, mice homozygous for the PAPP-A2
deletion were smaller, while there was no evidence of a difference
between heterozygotes and homozygous wild-types (Table 4).
In analyses of the linear dimensions of bones, MANOVA
identified a significant effect of genotype on bones of the skull (skull
and mandible dimensions; Wilks’ Lambda F6,114 = 17.81;
P= 0.0001) and the long bones (humerus, radius/ulna, femur
and tibia; Wilks’ Lambda F8,114 = 6.26; P = 0.0001), and so further
single variable tests were performed. As with body mass and tail
length, the effect of PAPP-A2 deletion did not depend on sex;
genotype by sex interaction was not significant for any trait and so
was removed from the model. Consistent with the highly
significant effect on 10 week body mass and tail length, PAPP-
A2 deletion had a significant effect on mandible dimensions and
Table 1. Predicted phenotypic comparisons in offspring from the quantitative complementation test if Pappa2 is or is not the
quantitative trait gene (QTG), i.e., the gene responsible for the effect of the QTL.
Mouse heterozygous for constitutive Pappa2 disruption (on C57BL6 background)
X
Mouse heterozygous for C57BL6 and DBA2 QTL alleles (on DBA2 background)
Q
Offspring of four possible genotypes:
disrupted or intact C57BL6 Pappa2 allele from one parent, and C57BL6 or DBA2 QTL from other parent
C57BL6/disrupted DBA2/disrupted C57BL6/intact DBA2/intact
If Pappa2 is responsible for the effect of the QTL, the
genotype at the QTG will be:
C57BL6/disrupted DBA2/disrupted C57BL6/C57BL6 DBA2/C57BL6
Prediction: The phenotypic difference between C57BL6/disrupted and DBA2/disrupted will be greater
than the phenotypic difference between C57BL6/C57BL6 and DBA2/C57BL6. Little difference is expected
between the C57BL6/C57BL6 and DBA2/C57BL6 genotypes because the C57BL6 allele is partially dominant
[12].
If Pappa2 is not responsible for the effect of the QTL, The
genotype at the QTG will therefore be:
C57BL6/C57BL6 DBA2/C57BL6 C57BL6/C57BL6 DBA2/C57BL6
All offspring will inherit an intact C57BL6 allele at the QTG, even where they inherit a disrupted Pappa2
allele.
Prediction: The phenotypic difference between C57BL6/disrupted-Pappa2 and DBA2/disrupted-Pappa2
will be equal to the phenotypic difference between C57BL6/intact-Pappa2 and DBA2/intact-Pappa2.
doi:10.1371/journal.pone.0056260.t001
Table 2. Primer sequences.
Pappa2 allele genotyping
KO proximal CAGCAAAGGAAATTTGTGCT
KO distal ATTCCTCAGCCTCCTCTGAT
KO exon CTTCGATGATGGAGACTGCT
KO neo GGATTGGGAAGACAATAGCA
QTL allele genotyping
Proximal forward GGTGTTGTGGGTGAGACATT
Proximal reverse AAACATAAAGTAGACATGCTTCCA
Distal forward CCTGTCTGACTCACGAAGAAA
Distal reverse GGTCATGGTCTCTCTTCATACC
Cre genotyping
Cre forward GCGGTCTGGCAGTAAAAACTATC
Cre reverse GTGAAACAGCATTGCTGTCACTT
Positive control forward CTAGGCCACAGAATTGAAAGATCT
Positive control reverse GTAGGTGGAAATTCTAGCATCATCC
doi:10.1371/journal.pone.0056260.t002
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the lengths of the skull, humerus, femur, tibia, pelvic girdle, and
tail bone (Table 4); the effect on the length of the ulna/radius was
marginally non-significant (F2,60 = 2.71; P= 0.08). In all cases,
mice homozygous for the PAPP-A2 deletion had shorter bones,
while bone size was similar in heterozygotes and homozygous
wild-types. To determine whether effects on bone dimensions were
due to a general effect on size, or whether certain bones were
affected disproportionately, we repeated the analysis while
controlling for 10 week body mass (by including body mass as
a covariate in the model). Effects of genotype on the humerus,
ulna/radius and tibia were not significant when controlling for
body mass (data not shown). However, there remained significant
effects on mandible dimensions and the lengths of the skull, femur,
pelvic girdle, and tail bone with smaller bones in homozygous
knock-out mice, even when body mass was included as a covariate
(data not shown), i.e., the length of these bones was reduced more
than would be expected given the effect of PAPP-A2 deletion on
body mass.
In contrast to the effects of PAPP-A2 deletion on bone lengths,
there was no effect of Pappa2 genotype on the dry masses of the
stomach, spleen, pancreas, kidneys, liver, lungs or heart (MAN-
OVA Wilks’ Lambda F16,100 = 1.42; P = 0.15).
Effects of PAPP-A2 Deletion on Bone Shape
The Procrustes analysis used to remove variation in position,
orientation and size from bone landmark data yielded centroid
size, which is a measure of overall bone size. Consistent with the
linear measures described above, deletion of PAPP-A2 had a highly
significant effect on the centroid size of both the mandible and
pelvic girdle (P,0.0001 in both cases), with mice homozygous for
Pappa2 disruption having smaller bones, and heterozygotes and
homozygous wild-type mice having bones of similar size.
In Principal Component Analysis of the Procrustes coordinates,
the first two principal components explained 47% and 34% of the
variation in size-independent shape of mandibles and pelvic
girdles, respectively; subsequent principal components each
explained less than 12% of the variation. Plotting the second
principal component (PC2) against the first (PC1) illustrates
differences in bone shape between mice homozygous for Pappa2
disruption and those with at least one functional copy of Pappa2, as
well as differences between sexes (Figs. 3A and 3B). Including sex
and litter as terms in the model, there was significant variation
among Pappa2 genotypes in mandible PC2 (F2,50 = 8.70;
P= 0.0006) but not PC1 (F2,50 = 0.87; P= 0.43). As with measures
of size, shape in heterozygous mice was much more similar to
homozygous wild-types than to mice homozygous for Pappa2
disruption. In mandibles, PC2 includes variation in the distance
between the tips of the angular and coronoid processes (Fig. 3A).
Mice homozygous for the Pappa2 disruption have more negative
values of PC2 (Fig. 3A), which indicates a smaller distance between
the tips of the angular and coronoid processes, i.e., a less deep
bone.
There was also significant variation among Pappa2 genotypes in
pelvic girdle PC1 (F2,58 = 9.26; P= 0.0003), but not pelvic girdle
PC2 (F2,58 = 0.13; P= 0.88), including sex and litter as terms in the
model. As with above, shape in heterozygous mice was much more
similar to homozygous wild-types than to mice homozygous for
Pappa2 disruption. Pelvic girdle PC1 largely reflects variation in
the shape of the ischium, as well as the length of the pubis and, to
a lesser extent, the width of the end of the ilium (Fig. 3B). This
captured the sexual dimorphism in pelvic girdle shape, with little
overlap in PC1 between males and females. Mice homozygous for
the Pappa2 disruption had significantly lower PC1 scores,
suggesting a more ‘‘female’’ shape, i.e., male knock-outs were
Figure 2. Effects of gene disruption on PAPP-A2 protein. Shown are Western blots of 9 representative (A) placentae and (B) embryos at
embryonic day 12.5 from embryos homozygous for wild-type Pappa2 (+/+), heterozygous (+/2) or homozygous for the disruption (2/2). The
nitrocellulose membrane was scanned for fluorescence at 700 and 800 nm simultaneously, with fluorescence at 700 nm corresponding to actin (at
approximately 40 kDa) and fluorescence at 800 nm corresponding to PAPP-A2 (at approximately 250 kDa).
doi:10.1371/journal.pone.0056260.g002
Table 3. Offspring genotype frequencies in crosses between
mice heterozygous for the Pappa2 disruption (2/
2=homozygous for Pappa2 disruption, +/2=heterozygous,
+/+=homozygous for wild-type Pappa2).
Stage 2/2 2/+ +/+ P-valuea
E12.5 3 5 6 0.30
Birth 14 37 11 0.27
Weaningb 24 53 18 0.36
aChi-square test of null hypothesis that genotypes are in 1:2:1 ratio.
bThe sample measured at weaning and into adulthood includes 50 females and
45 males.
doi:10.1371/journal.pone.0056260.t003
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more similar to females than were other males, and female knock-
outs had a more extreme female shape than the other females.
Because there was such a striking sexual dimorphism in pelvic
girdle shape, we repeated the Principal Components analysis with
females only, so that variation between the sexes would not
influence the PC scores. The difference in PC1 between females
homozygous for the disruption and females with at least one
functional copy of Pappa2 remained significant and the variation in
shape associated with PC1 was very similar to that depicted in
Fig. 3B (data not shown).
Quantitative Complementation Test
A quantitative complementation test was performed to test
whether Pappa2 is the gene responsible for a previously-described
QTL affecting body size. The prediction is that, if Pappa2 is the
gene responsible for the effect of the QTL, the phenotypic
difference between QTL genotypes will be greater in mice who
inherited a disrupted Pappa2 allele than in mice who inherited
a wild-type Pappa2 allele from their heterozygous disruption parent
(Table 1). The mean values fit this prediction for tail length and
body mass at 3, 6, and 10 weeks of age (Fig. 4), with mice
inheriting a DBA/2 allele and a disrupted Pappa2 allele having the
lowest values. In MANOVA, the statistical interaction between
Pappa2 disruption genotype and QTL genotype was significant for
body mass (Wilks’ Lambda F3,200 = 3.60; P= 0.014) and tail length
(Wilks’ Lambda F3,198 = 6.00; P= 0.0006) at 3, 6 and 10 weeks.
However, in single variable tests, the interaction was significant
only for tail length at 3, 6 and 10 weeks (F1,201 = 6.60; P = 0.01,
F1,201 = 7.93; P= 0.005, and; F1,200 = 15.45; P= 0.0001, respec-
tively) and for body mass at 3 weeks (F1,203 = 9.71; P = 0.002), but
not at 6 or 10 weeks (F1,203 = 1.81; P = 0.18 and F1,202 = 0.11;
P= 0.74, respectively). Litter and sex were also included as terms
in the model in these analyses. The quantitative complementation
test therefore established that Pappa2 is responsible for at least part
of the effect of the QTL.
The interaction between Pappa2 disruption genotype and QTL
genotype was marginally non-significant for the bones of the skull
(skull and mandible dimensions; MANOVA Wilks’ Lambda
F3,194 = 2.22; P = 0.09) and not significant for the long bones
(humerus, radius/ulna, femur and tibia; MANOVA Wilks’
Lambda F4,194 = 0.20; P= 0.94). In single variable analyses, the
quantitative complementation test was significant for mandible
length (F1,198 = 5.66; P= 0.02), the length of the pelvic girdle
(F1,198 = 3.90; P= 0.05) and was marginally non-significant for
mandible height (F1,196 = 3.60; P= 0.06), and the centroid sizes of
the mandible (F1,189 = 3.55; P= 0.06) and pelvic girdle
(F1,201 = 2.83; P = 0.09), but not significant for any other linear
bone measurements or shape measurements (data not shown).
While the interaction was not significant, the expected trend (see
Table 1) was observed for all linear bone measurements.
Discussion
We have shown that deletion of PAPP-A2 reduces the lengths of
some bones beyond what is expected due to reduced body size,
and also affects bone shape. In particular, we found changes in
pelvic girdle shape, providing a potential explanation for the
previously-reported associations between Pappa2 SNPs and de-
velopmental dysplasia of the hip in humans [17] and birthing in
cattle [10]. We found a substantial sexual dimorphism in pelvic
girdle shape, consistent with previous work [25], and the pelvic
girdle of mice homozygous for the Pappa2 disruption had a more
feminine shape, in addition to being disproportionately small for
a given body size. Natural variation in the Pappa2 gene could
therefore increase the risk of birthing complications through
a reduction in PAPP-A2 expression or activity leading to reduced
pelvic girdle size and/or to an extreme female shape that was
suboptimal for giving birth. Alternatively, a SNP that increased
PAPP-A2 activity or expression might lead to a pelvic girdle with
a more masculine shape, which could also cause difficulties during
birth.
Deletion of PAPP-A2 also affected the shape of the mandible,
with mice homozygous for the disruption having a smaller distance
between the tips of the angular and coronoid processes, i.e., a less
deep bone. We therefore hypothesize that natural variation in
Pappa2 is a potential source of variation for evolutionary
adaptations in mandible shape, e.g., in response to digging
behaviour [26] or diet [27,28]. For example, shallower mandibles
have been associated with a more omnivorous diet, whereas
deeper, more robust mandibles have been associated with diets
which required more powerful mastication [27].
Table 4. Phenotypes in offspring homozygous for Pappa2
disruption (2/2), heterozygous (+/2), or homozygous for
wild-type Pappa2 (+/+), from crosses between mice
heterozygous for the Pappa2 disruption.
2/2 2/+ +/+ P-valuea
Placental mass
at E12.5 (g)
0.0960.01 0.1060.01 0.1160.01 0.55b
Embryonic mass
at E12.5 (g)
0.1460.01 0.1460.01 0.1460.01 1.00b
Birth mass (g) 1.2560.03 1.3160.02 1.3260.03 0.09c
3 week mass (g) 7.2560.21 8.1460.14 8.2060.24 0.002d
3 week tail length (cm) 6.0660.11 6.3260.07 6.4060.11 0.08d
6 week mass (g) 14.7960.40 17.4160.26 17.6060.46 0.0001d
6 week tail length (cm) 6.9660.10 7.4160.06 7.3560.12 0.004d
10 week mass (g) 18.9360.31 21.9160.19 21.9560.36 0.0001d
10 week tail length (cm) 7.6560.06 8.2860.03 8.2360.07 0.0001d
Mandible length (mm) 7.8760.03 8.2960.02 8.2960.04 0.0001d
Mandible height (mm) 5.8960.03 6.3460.02 6.3460.04 0.0001d
Skull (mm) 21.4360.09 22.2360.07 22.0760.11 0.0001d
Humerus (mm) 11.2460.06 11.5560.04 11.4960.07 0.0003d
Ulna/radius (mm) 13.0760.08 13.2960.06 13.2360.09 0.07d
Femur (mm) 14.1760.07 14.7860.05 14.6660.08 0.0001d
Tibia (mm) 16.4260.07 16.8360.05 16.7060.09 0.0003d
Pelvic girdle (mm) 16.4260.14 17.5760.10 17.4860.17 0.0001d
Tail bone (mm) 3.3460.05 3.7260.03 3.7260.05 0.0001d
Values are least squares means 6 standard error.
aP-values are provided for the test of whether there is significant variation
among the three genotypes.
bSample sizes are as in Table 3. Placentae and embryos were collected from two
pregnant females. Genotype and female were included as terms in the model.
cSample sizes are as in Table 3. Pups from 7 litters were measured. Genotype
and litter were included as terms in the model.
dSample sizes for body mass are approximately as in Table 3, although are lower
in some cases because of missed measurements. Sample sizes for bone
measurements are smaller (total N = 73) because some mice were used for
further breeding and so were not sacrificed at 10 weeks of age. Offspring from
11 litters were measured. Sample sizes for tail length are substantially smaller
(total N = 27–30) because this trait could not be measured in individuals for
which birth mass was obtained since the tip of the tail was collected for
genotyping. Genotype, litter and sex were included as terms in the model.
doi:10.1371/journal.pone.0056260.t004
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Figure 3. Effects of gene disruption on mandible and pelvic girdle shape. In the scatterplots of the first and second principal components of
(A) mandible landmark data and (B) pelvic girdle landmark data, black/red symbols are females, open/blue symbols are males, squares are
homozygous wild-type, diamonds are heterozygotes and circles are homozygous Pappa2 disruption. To highlight the effects of disruption, symbols
for homozygote knock-out females are red and those for homozygote knock-out males are blue. Outlines above the graph illustrate variation in
shape measured by the first principal component, and represent extremes in shape (PC1=20.1 and 0.1) to facilitate visualization. Outlines to the
right of the graph illustrate variation in the second principal component. Dots on the outlines indicate the location of landmarks. Note that analyses
are carried out on the locations of landmarks, and outlines are drawn only to visualize changes in shape; outlines should therefore be interpreted with
caution. Because of broken, damaged or missing bones, sample sizes were reduced compared to analyses of body mass, and a total of 61 mandibles
and 71 pelvic girdles were analysed.
doi:10.1371/journal.pone.0056260.g003
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Unlike the study by Conover et al. [13], we did not find that the
effects of PAPP-A2 deletion differed between the sexes. Despite
high PAPP-A2 expression in the placenta [22], we did not find
prenatal effects of PAPP-A2 deletion, although there was a non-
significant trend towards lower birth mass in pups homozygous for
the Pappa2 disruption. A lack of effect on birth mass is consistent
with the previous study of PAPP-A2 knock-outs [13], as well as our
previous work examining variation in placental PAPP-A2 expres-
sion between QTL alleles [21].
The specific mechanisms through which the deletion of PAPP-
A2 affects bone size and shape requires further study, but we
expect that deletion of PAPP-A2 will lead to a reduction in
IGFBP-5 proteolytic activity and consequently higher levels of
intact IGFBP-5 and lower free IGF levels, leading to reduced
growth. In addition to the effects of IGFBP-5 on IGF availability,
IGFBP-5 may also have IGF-independent effects [15]. Because the
IGFBPs are thought to have important local actions in bone
[14,15], the consequences of PAPP-A2 deletion may be due to
local effects, and so PAPP-A2 deletion would not necessarily be
expected to influence circulating levels of IGFBP-5 or IGFs.
In addition to characterizing the effects of PAPP-A2 deletion on
skeletal phenotypes, the quantitative complementation test estab-
lished that Pappa2 is responsible for at least some of the effect of
a previously-described QTL [12]. The quantitative complemen-
tation test showed significant interactions for tail length at 3, 6 and
10 weeks and body mass at 3 weeks, and was significant or
marginally non-significant for measures of mandible and pelvic
girdle size, but was not significant for body mass at 6 or 10 weeks
or the sizes of any other bones. These results are consistent with
previous observations of the effects of the QTL. Previously, we
have found that the effects of the QTL on body mass are smaller
than those on tail length [29,30]. Furthermore, we have only
found effects of the QTL on the dimensions of the mandible and
tail bone, but not other long bones, although this earlier study used
a different measure of the pelvic girdle [16]. It is not clear whether
the lack of significance in the quantitative complementation tests
for bones other than mandible and pelvic girdle represents a real
lack of effect of the QTL or low statistical power. The quantitative
complementation test therefore demonstrates that natural varia-
tion in the Pappa2 gene, which exists between the inbred lines of
mice used in our previous QTL mapping work, contributes to
variation in at least some aspects of body size in mice. This is one
of the first instances in which the gene responsible for a QTL
affecting growth has been identified. This QTL is due to variation
between the C57BL/6 and DBA/2 alleles, and both of these
strains have been sequenced extensively. Many if not all of the
candidate variants between the alleles are therefore already
known, and can be used to investigate functionally important
coding and regulatory regions. Although it is not clear whether the
QTL is due to regulatory or coding sequence variation, we have
previously found differences in PAPP-A2 expression levels between
QTL genotypes [21].
In conclusion, our results show that natural variation in the
Pappa2 gene can contribute to variation in postnatal growth. If
similar functional variation in the Pappa2 gene exists in other
species, effects of this variation on the shape of the pelvic girdle
could potentially explain the previously-reported associations
between SNPs in Pappa2 and pelvic bone-related phenotypes such
as hip dysplasia and birthing ease.
Acknowledgments
We thank Lauren Rafuse, Barinder Sangha, Pamela Wagner and Chauntel
Watts for technical help, the staff of the animal care facility at Simon Fraser
University for assistance with sample collection, staff at Ozgene for the
development of the conditional PAPP-A2 deletion mice, and two
anonymous reviewers for constructive comments.
Author Contributions
Conceived and designed the experiments: JKC. Performed the experi-
ments: JKC SHYF. Analyzed the data: JKC DRDZ. Wrote the paper:
JKC DRDZ SHYF.
References
1. Bunn RC, Fowlkes JL (2003) Insulin-like growth factor binding protein
proteolysis. Trends Endocrin Met 14: 176–181.
2. Christians JK, Gruslin A (2010) Altered levels of insulin-like growth factor
binding protein proteases in preeclampsia and intrauterine growth restriction.
Prenatal Diag 30: 815–820.
3. Chen BK, Leiferman KM, Pittelkow MR, Overgaard MT, Oxvig C, et al. (2003)
Localization and regulation of pregnancy-associated plasma protein a expression
in healing human skin. J Clin Endocrinol Metab 88: 4465–4471.
4. Conover CA, Bale LK (2007) Loss of pregnancy-associated plasma protein A
extends lifespan in mice. Aging Cell 6: 727–729.
5. Kaski JC, Holt DW (2006) Pregnancy-associated plasma protein-A and
cardiovascular risk. Eur Heart J 27: 1637–1639.
6. Tanner SJ, Hefferan TE, Rosen CJ, Conover CA (2008) Impact of pregnancy-
associated plasma protein-A deletion on the adult murine skeleton. J Bone Miner
Res 23: 655–662.
7. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, et al.
(2001) Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like
growth factor-binding protein-5 proteinase. J Biol Chem 276: 21849–21853.
8. Yan XL, Baxter RC, Firth SM (2010) Involvement of pregnancy-associated
plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5
proteolysis during pregnancy: A potential mechanism for increasing IGF
bioavailability. J Clin Endocrinol Metab 95: 1412–1420.
9. Luna-Nevarez P, Rincon G, Medrano JF, Riley DG, Chase CC Jr, et al. (2011)
Single nucleotide polymorphisms in the growth hormone-insulin-like growth
factor axis in straightbred and crossbred Angus, Brahman, and Romosinuano
heifers: Population genetic analyses and association of genotypes with
reproductive phenotypes. J Anim Sci 89: 926–934.
10. Wickramasinghe S, Rincon G, Medrano JF (2011) Variants in the pregnancy-
associated plasma protein-A2 gene on Bos taurus autosome 16 are associated
with daughter calving ease and productive life in Holstein cattle. J Dairy Sci 94:
1552–1558.
11. Luna-Nevarez P, Rincon G, Medrano JF, Riley DG, Chase CC Jr, et al. (2012)
Identification of one polymorphism from the PAPP-A2 gene associated to
fertility in Romosinuano beef heifers raised under a subtropical environment.
Revista Mexicana De Ciencias Pecuarias 3: 185–200.
12. Christians JK, Hoeflich A, Keightley PD (2006) PAPPA2, an enzyme that
cleaves an insulin-like growth-factor-binding protein, is a candidate gene for
a quantitative trait locus affecting body size in mice. Genetics 173: 1547–1553.
13. Conover CA, Boldt HB, Bale LK, Clifton KB, Grell JA, et al. (2011) Pregnancy-
associated plasma protein-A2 (PAPP-A2): Tissue expression and biological
consequences of gene knockout in mice. Endocrinology 152: 2837–2844.
14. Conover CA (2008) Insulin-like growth factor-binding proteins and bone
metabolism. Am J Physiol - Endoc M 294: E10–E14.
15. Govoni KE, Baylink DJ, Mohan S (2005) The multi-functional role of insulin-
like growth factor binding proteins in bone. Pediatr Nephrol 20: 261–268.
16. Christians JK, Senger LK (2007) Fine mapping dissects pleiotropic growth
quantitative trait locus into linked loci. Mamm Genome 18: 240–245.
17. Jia J, Li L, Zhao Q, Zhang L, Ru J, et al. (2012) Association of a single
nucleotide polymorphism in pregnancy-associated plasma protein-A2 with
Figure 4. Quantitative complementation test. Body mass and tail length at 3, 6 and 10 weeks of age are shown for mice homozygous for wild-
type Pappa2 (+/+) or heterozygous for the Pappa2 disruption (+/2) and homozygous for the C57BL6 QTL allele (squares) or heterozygous for the
DBA2 and C57BL6 QTL alleles (triangles). In all cases, the difference between QTL alleles is greater for +/2 mice than for +/+ mice, consistent with
what is predicted if Pappa2 is the gene responsible for the QTL. The total sample size for the quantitative complementation test was 243 (133 females
and 110 males), although is slightly lower for some traits due to missed measurements.
doi:10.1371/journal.pone.0056260.g004
Effects of PAPP-A2 on Bone Size and Shape
PLOS ONE | www.plosone.org 9 February 2013 | Volume 8 | Issue 2 | e56260
developmental dysplasia of the hip: a case-control study. Osteoarth Cartilage 20:
60–63.
18. Cheverud JM, Fawcett GL, Jarvis JP, Norgard EA, Pavlicev M, et al. (2010)
Calpain-10 is a component of the obesity-related quantitative trait locus Adip1.
J Lipid Res 51: 907–913.
19. Christians JK, Keightley PD (2005) Behavioural genetics: Finding genes that
cause complex trait variation. Curr Biol 15: R19–R21.
20. Yalcin B, Willis-Owen SAG, Fullerton J, Meesaq A, Deacon RM, et al. (2004)
Genetic dissection of a behavioral quantitative trait locus shows that Rgs2
modulates anxiety in mice. Nat Genet 36: 1197–1202.
21. Wagner PK, Christians JK (2010) Altered placental expression of PAPPA2 does
not affect birth weight in mice. Reprod Biol Endocrin 8: 90.
22. Wang J, Qiu Q, Haider M, Bell M, Gruslin A, et al. (2009) Expression of
pregnancy-associated plasma protein A2 during pregnancy in human and
mouse. J Endocrinol 202: 337–345.
23. Klingenberg CP (2011) MorphoJ: an integrated software package for geometric
morphometrics. Mol Ecol Resour 11: 353–357.
24. Klingenberg CP (2010) Evolution and development of shape: integrating
quantitative approaches. Nat Rev Genet 11: 623–635.
25. Schutz H, Donovan ER, Hayes JP (2009) Effects of parity on pelvic size and
shape dimorphism in Mus. J Morphol 270: 834–842.
26. Alvarez A, Ivan Perez S, Verzi DH (2011) Ecological and phylogenetic influence
on mandible shape variation of South American caviomorph rodents (Rodentia:
Hystricomorpha). Biol J Linn Soc 102: 828–837.
27. Renaud S, Michaux JR (2003) Adaptive latitudinal trends in the mandible shape
of Apodemus wood mice. J Biogeogr 30: 1617–1628.
28. Monteiro LR, Duarte LC, dos Reis SF (2003) Environmental correlates of
geographical variation in skull and mandible shape of the punare rat
Thrichomys apereoides (Rodentia : Echimyidae). J Zool 261: 47–57.
29. Christians JK, Bingham V, Oliver F, Heath TT, Keightley PD (2003)
Characterization of a QTL affecting skeletal size in mice. Mammalian Genome
14: 175–183.
30. Christians JK, Keightley PD (2004) Fine mapping of a murine growth locus to
a 1.4-cM region and resolution of linked QTL. Mammalian Genome 15: 482–
491.
Effects of PAPP-A2 on Bone Size and Shape
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e56260
